Asensus Surgical Inc (NYSE American:ASXC)

0.8101
Delayed Data
As of Jan 27
 -0.0699 / -7.94%
Today’s Change
0.73
Today|||52-Week Range
6.95
-27.02%
Year-to-Date
SECTOR
Commercial Services
INDUSTRY
Miscellaneous Commercial Services
MARKET CAP
$198.0M

Company Description

Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, economic shortcomings in surgery. The Senhance Surgical System features as the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling on August 19, 1988 and is headquartered in Morrisville, NC.

Contact Information

Asensus Surgical, Inc.
1 TW Alexander Drive
Durham North Carolina 27703
P:(919) 765-8400
Investor Relations:
(443) 213-0501

Employees

Shareholders

Other institutional5.00%
Mutual fund holders21.25%
Individual stakeholders0.55%

Top Executives

Anthony FernandoPresident Chief Executive Officer & Director
Shameze RampertabChief Financial Officer & Executive Vice President
Cameron PedersenVice President-Global Research & Development
Eric SmithChief Commercial Officer
Mark KlausnerInvestor Relations Contact